TMCI in the 13F filings
Treace Med Concepts Inc · CUSIP 89455T109
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 19 Feb 2026
- latest of these filings; the earliest 4 Feb 2026
- Managers listing it
- 15
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 2 listed it in both
- Shares listed
- 5,378,285
- combined, among listed positions
- Reported value
- $13m
- combined, at the quarter end
Among the 92 comparable managers: 8 buyers (opened or added shares) and 10 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +573,094.
Managers listing TMCI in Q4 2025
15 of 15 holders
Largest increases and reductions, by shares
Increases
- Acadian Asset Management LLCexisting position · 662,785 shares now+390,848
- First Eagle Investment Management LLCexisting position · 1,462,983 shares now+224,088
- Citadel Advisors LLCnew position · 211,906 shares now+211,906
- Point72 Asset Management LPnew position · 169,792 shares now+169,792
- Jane Street Group LLCexisting position · 177,008 shares now+131,478
Reductions
- Millennium Management LLCexisting position · 1,502,911 shares now-207,229
- D. E. Shaw & Co.existing position · 630,130 shares now-131,203
- Invesco Ltdexisting position · 25,020 shares now-2,711
- Verition Fund Management LLCexisting position · 21,973 shares now-502
- Schonfeld Strategic Advisors LLCexisting position · 62,674 shares now-373
New positions and exits
New (3)
Exited (5)
- Tudor Investment Corpwas $960k
- AQR Capital Management LLCwas $871k
- Brevan Howard Capital Management LPwas $207k
- Squarepoint Ops LLCwas $195k
- Marshall Wace LLPwas $79k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2021 | 1 | $1.3m | n.a. | n.a. |
| Q3 2022 | 2 | $72m | n.a. | n.a. |
| Q4 2022 | 2 | $74m | n.a. | n.a. |
| Q1 2023 | 2 | $82m | n.a. | n.a. |
| Q2 2023 | 4 | $128m | n.a. | n.a. |
| Q3 2023 | 1 | $16m | n.a. | n.a. |
| Q1 2025 | 2 | $4.9m | 2 | 0 |
| Q2 2025 | 1 | $5.3m | 1 | 0 |
| Q3 2025 | 2 | $9.3m | 2 | 0 |
| Q4 2025 | 2 | $4.1m | 8 | 10 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
TMCI and LLY →TMCI and JNJ →TMCI and VRTX →Choose a stock to compare with TMCI →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own TMCI, latest filings →Back to the 13F Explorer →